Unknown

Dataset Information

0

Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking.


ABSTRACT: AIM: To construct a quantitative pharmacophore model of tubulin inhibitors and to discovery new leads with potent antitumor activities. METHODS: Ligand-based pharmacophore modeling was used to identify the chemical features responsible for inhibiting tubulin polymerization. A set of 26 training compounds was used to generate hypothetical pharmacophores using the HypoGen algorithm. The structures were further validated using the test set, Fischer randomization method, leave-one-out method and a decoy set, and the best model was chosen to screen the Specs database. Hit compounds were subjected to molecular docking study using a Molecular Operating Environment (MOE) software and to biological evaluation in vitro. RESULTS: Hypo1 was demonstrated to be the best pharmacophore model that exhibited the highest correlation coefficient (0.9582), largest cost difference (70.905) and lowest RMSD value (0.6977). Hypo1 consisted of one hydrogen-bond acceptor, a hydrogen-bond donor, a hydrophobic feature, a ring aromatic feature and three excluded volumes. Hypo1 was validated with four different methods and had a goodness-of-hit score of 0.81. When Hypo1 was used in virtual screening of the Specs database, 952 drug-like compounds were revealed. After docking into the colchicine-binding site of tubulin, 5 drug-like compounds with the required interaction with the critical amino acid residues and the binding free energies < -4 kcal/mol were selected as representative leads. Compounds 1 and 3 exhibited inhibitory activity against MCF-7 human breast cancer cells in vitro. CONCLUSION: Hypo1 is a quantitative pharmacophore model for tubulin inhibitors, which not only provides a better understanding of their interaction with tubulin, but also assists in discovering new potential leads with antitumor activities.

SUBMITTER: Niu MM 

PROVIDER: S-EPMC4088285 | biostudies-literature | 2014 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking.

Niu Miao-Miao MM   Qin Jing-Yi JY   Tian Cai-Ping CP   Yan Xia-Fei XF   Dong Feng-Gong FG   Cheng Zheng-Qi ZQ   Fida Guissi G   Yang Man M   Chen Hai-Yan HY   Gu Yue-Qing YQ  

Acta pharmacologica Sinica 20140609 7


<h4>Aim</h4>To construct a quantitative pharmacophore model of tubulin inhibitors and to discovery new leads with potent antitumor activities.<h4>Methods</h4>Ligand-based pharmacophore modeling was used to identify the chemical features responsible for inhibiting tubulin polymerization. A set of 26 training compounds was used to generate hypothetical pharmacophores using the HypoGen algorithm. The structures were further validated using the test set, Fischer randomization method, leave-one-out m  ...[more]

Similar Datasets

| S-EPMC8410400 | biostudies-literature
| S-EPMC3558715 | biostudies-literature
| S-EPMC8783753 | biostudies-literature
| S-EPMC3036604 | biostudies-literature
| S-EPMC6396084 | biostudies-literature
| S-EPMC9913026 | biostudies-literature
| S-EPMC10800075 | biostudies-literature
| S-EPMC7571137 | biostudies-literature
| S-EPMC10863211 | biostudies-literature
| S-EPMC3985759 | biostudies-literature